Magdy Wasfy, Reham
Abdoulaye, Anissa
Borentain, Patrick
Mbaye, Babacar
Tidjani Alou, Maryam
Caputo, Aurelia
Andrieu, Claudia
Mottola, Giovanna
Levasseur, Anthony
Million, Matthieu
Gerolami, Rene
Funding for this research was provided by:
ANR "Investissements d'avenir", Méditerranée Infection 10-IAHU-03. (ANR-15-CE36-0004-01, ANR-15-CE36-0004-01, ANR-15-CE36-0004-01, ANR-15-CE36-0004-01)
Article History
Received: 8 September 2024
Accepted: 21 April 2025
First Online: 7 May 2025
Declarations
:
: The HEPATGUT study was approved by the local ethics committee of the Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (IHUMI, 2020-004), approved by the Protection of Persons Committee (Approval No. CPP: 21.04391.000046—21075), and carried out according to the 2013 Declaration of Helsinki (World Medical Association, 2013). Patient consent (non-opposition) was obtained according to French regulations.
: Not applicable.
: The authors declare no competing interests.
: No conflict of interest is to be declared.